Neoadjuvant chemoradiation therapy is beneficial for clinical stage T2 N0 esophageal cancer patients due to inaccurate preoperative staging

Annals of Thoracic Surgery

Volumn 93, Issue 2, 2012, Pages 429-437

  Zhang, Jennifer Q ^a   Hooker, Craig M ^a,b   Brock, Malcolm V ^a   Shin, James ^a   Lee, Sue ^a   How, Remealle ^a   Franco, Noreli ^a   Prevas, Helen ^a   Hulbert, Alicia ^a   Yang, Stephen C ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

American Society of Anesthesiologists; ASA; CI; clinical stage T2 N0; computed tomography; confidence interval; CT; cT2 N0; endoscopic ultrasound; EUS; hazard ratio; HR; interquartile range; IQR; margin negative; margin positive; pathologic stage T2 N0; PET; positron emission tomography; pT2 N0; R0; R1

Indexed keywords

CAPECITABINE; FLUOROURACIL; IRINOTECAN; PACLITAXEL; PLATINUM;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; ESOPHAGUS CANCER; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DIAGNOSTIC ERRORS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; INDUCTION CHEMOTHERAPY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84862962803     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2011.10.061     Document Type: Article

References (15)

1. A. Rohatgi, S. Naji, A. Hamouda Effect of understaging of early oesophageal cancers on treatment J Clin Oncol 27 suppl 2009 abstr e15572
2. C. Mariette, F. Seitz, E. Maillard Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer: analysis of a randomized controlled phase III trial FFCD 9901 J Clin Oncol 28 15 suppl 2010 abstr 4005
3. M. Hurmuzlu, K. Øvrebø, O.R. Monge, R. Smaaland, T. Wentzel-Larsen, A. Viste High-dose chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer: a retrospective cohort study World J Surg Oncol 8 2010 46
4. B. Stiles, F. Mirza, A. Coppolino Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease Ann Thorac Surg 92 2011 491 498
5. T. Rice, D. Mason, S. Murthy T2N0M0 esophageal cancer J Thorac Cardiovasc Surg 133 2007 317 324
6. H. Matsubara Neoadjuvant chemoradiation therapy for the treatment of esophageal carcinoma Intl J Clin Oncol 13 2008 474 478
7. F.P.D. Greene, I. Fleming, A. Fritz Esophagus AJCC cancer staging handbook 6th ed. 2002 Springer-Verlag New York 91 95
8. A.S. Keats The ASA classification of physical statusa recapitulation Anesthesiology 49 1978 233 236
9. T. Rice, V. Rusch, H. Ishwaran, E. Blackstone Cancer of the esophagus and esophagogastric junction Cancer 2010 3763 3773
10. M. Orditura, G. Galizia, F. Morgillo Complete response to preoperative chemoradiation and survival in esophageal cancer: a pooled analysis of three single-institution phase II trials Dis Esophagus 2011 1442 2050
11. R.A. Meguid, C.M. Hooker, J.T. Taylor Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: Does the pattern of recurrence differ for patients with complete response and those with partial or no response? Gen Thorac Surg 138 2009 1309 1316
12. T. Rice, E. Blackstone, V. Rusch A cancer staging primer: esophagus and esophagogastric junction J Thorac Cardiovasc Surg 139 2010 527 529
13. A. Alexandrou, P.A. Davis, S. Law Squamous cell carcinoma and adenocarcinoma of the lower third of the esophagus and gastric cardia: similarities and differences Dis Esophagus 15 2002 290 295
14. N.M. Gupta, R. Jindal, O. Prakash Comparison of the clinical profile and outcome for squamous cell carcinoma and adenocarcinoma of the distal esophagus and cardia in India Surg Today 31 2001 400 404
15. J.D. Salazar, J.R. Doty, J.W. Lin Does cell type influence post-esophagectomy survival in patients with esophageal cancer? Dis Esophagus 11 1998 168 171